Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treg to Th17 conversion in human skin inflammation
NL-OMON36028Active, not recruiting
- Sponsor
- Radboud University Medical Center
- Start
- Oct 2011
- Modality
- Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label trial of imiquimod and Leukotriene B4 in actinic keratosis (AK) and psoriasis (2 arms), sponsored by Radboud University Medical Center. Started Oct 2011; status: active, not recruiting.
02
Drugs
imiquimodLeukotriene B4
03
Conditions
actinic keratosis (AK)psoriasis
Beyond the preview
Go deeper on NL-OMON36028.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON36028.